Literature DB >> 1475299

Effect of scopolamine and nootropic drugs on rewarded alternation in a T-maze.

L Bartolini1, R Risaliti, G Pepeu.   

Abstract

The effects of different doses of scopolamine, and of the nootropic drugs oxiracetam and aniracetam, were investigated on the performance of male Wistar rats in a T-maze requiring a spatial discrimination in the stem (reference memory) and an alternate discrimination in the arms (working memory). Criterion (90% correct responses) was reached within 3 days of daily training for stem and 9 days for arm discrimination. Scopolamine (0.1, 0.2, 0.6, and 1.0 mg/kg, SC, 60 min before session) significantly impaired working memory, as shown by a decrease in the number of correct alternations, without affecting reference memory. Both nootropic drugs (25-50 and 100 mg/kg PO) 30 min before scopolamine) attenuated the working memory impairment induced by scopolamine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1475299     DOI: 10.1016/0091-3057(92)90497-4

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humans.

Authors:  Jan Laczó; Hana Markova; Veronika Lobellova; Ivana Gazova; Martina Parizkova; Jiri Cerman; Tereza Nekovarova; Karel Vales; Sylva Klovrzova; John Harrison; Manfred Windisch; Kamil Vlcek; Jan Svoboda; Jakub Hort; Ales Stuchlik
Journal:  Psychopharmacology (Berl)       Date:  2016-11-24       Impact factor: 4.530

Review 2.  Therapeutic potential of positive AMPA modulators and their relationship to AMPA receptor subunits. A review of preclinical data.

Authors:  Mark D Black
Journal:  Psychopharmacology (Berl)       Date:  2005-01-26       Impact factor: 4.530

Review 3.  Cholinergic modulation of the hippocampal region and memory function.

Authors:  Juhee Haam; Jerrel L Yakel
Journal:  J Neurochem       Date:  2017-08       Impact factor: 5.372

Review 4.  Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders.

Authors:  C R Lee; P Benfield
Journal:  Drugs Aging       Date:  1994-03       Impact factor: 3.923

5.  Olanzapine treatment of adolescent rats causes enduring specific memory impairments and alters cortical development and function.

Authors:  Jean A Milstein; Ahmed Elnabawi; Monika Vinish; Thomas Swanson; Jennifer K Enos; Aileen M Bailey; Bryan Kolb; Douglas O Frost
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

6.  M2 muscarinic acetylcholine receptor knock-out mice show deficits in behavioral flexibility, working memory, and hippocampal plasticity.

Authors:  Thomas Seeger; Irina Fedorova; Fang Zheng; Tsuyoshi Miyakawa; Elena Koustova; Jesus Gomeza; Anthony S Basile; Christian Alzheimer; Jürgen Wess
Journal:  J Neurosci       Date:  2004-11-10       Impact factor: 6.709

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.